BCS and IVIVC Based Biowaivers
The term bioweber applies to the regulatory approval process when a document (application) is approved based on evidence of equivalence other than in vivo bioequivalence testing. For solid oral dosage forms, Bioweber is generally based on dissolution tests. • BCS is a scientific framework for classifying drug substances based on water solubility and intestinal permeability. In combination with drug lysis, BCS takes into account three major factors that determine the rate and extent of absorption of solid oral IR dosage forms: lysis, solubility, and intestinal permeability.
Related Conference of BCS and IVIVC Based Biowaivers
July 25-26, 2024
4th International Conference on Biomedicine & Pharmacotherapy
Prague, Czech Republic
BCS and IVIVC Based Biowaivers Conference Speakers
Recommended Sessions
- Advanced Drug Delivery System
- BCS and IVIVC Based Biowaivers
- Biological Medicine
- Biopharmaceutical Informatics
- Chemical and Analytical Strategies for Biosimilars
- Consequences of Brexit on Biosimilars
- Digital Pharma
- Drug Delivery Technology
- Drug Formulation
- Encapsulated Drugs
- Intellectual Property Rights
- Pharmaceutical Chemistry
- Pharmaceutical Manufacturing
- Pharmacogenomics
Related Journals
Are you interested in
- Advanced Pharmaceutical Technology - Pharma Conference 2024 (UAE)
- Bioequivalence and Bioavailability - Pharma Conference 2024 (UAE)
- Clinical Pharmacy and Pharmacy Practices - Pharma Conference 2024 (UAE)
- Digital Pharma and Marketing - Pharma Conference 2024 (UAE)
- Drug Discovery - Pharma Conference 2024 (UAE)
- Drug Discovery - Pharma Conference 2024 (UAE)
- Drug Discovery, Design & Development: Challenges and Approaches - Pharma Conference 2024 (UAE)
- Nano medicine and Biomedical Application - Pharma Conference 2024 (UAE)
- Novel Drug Delivery Systems, Biomarkers and Drug Targets - Pharma Conference 2024 (UAE)
- Pharmaceutical Analysis - Pharma Conference 2024 (UAE)
- Pharmaceutical Care and Health System - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical Innovation - Pharma Conference 2024 (UAE)
- Pharmaceutical manufacturing and Pharmacoeconomics - Pharma Conference 2024 (UAE)
- Pharmaceutical Microbiology - Pharma Conference 2024 (UAE)
- Pharmaceutical Nanotechnology - Pharma Conference 2024 (UAE)
- Pharmacogenomics and Pharmacoepidemiology - Pharma Conference 2024 (UAE)
- Pharmacology and Toxicology - Pharma Conference 2024 (UAE)
- Technology in Pharma Sciences - Pharma Conference 2024 (UAE)
- The future of Pharma R&D - Pharma Conference 2024 (UAE)